Stockholm, June 3, 2015 — Nasdaq (Nasdaq: NDAQ) announces that the trading in Corline Biomedical AB’s shares (short name: CLBIO) commenced today on Nasdaq First North in Stockholm. Corline belongs to the Healthcare sector and is the 37th company to be admitted to trading on Nasdaq’s Nordic markets* in 2015.
Corline develops, manufactures and markets heparin-based solutions to improve kidney transplantation, cell therapies and applications in the evolving field of regenerative medicine. Using the same heparin technology platform - CHC™ - Corline also provides best-in-class surface coatings, making medical device implants blood and biocompatible. For more information, please visit www.corline.com.
“Corline Biomedical has a portfolio of very promising pharma development projects developing towards clinical trials, while at the same time delivering products to the medical device industry,” said Henrik Nittmar CEO of Corline Biomedical AB. “Becoming a publically traded company on Nasdaq First North gives the company a platform to invest in and successfully develop current and future projects for long-term value creation.”
“We welcome Corline to Nasdaq First North and to our family of companies,” said Adam Kostyál, senior vice president and head of European listings at Nasdaq. “Corline joins many entrepreneurial growth companies within the life science sector that use their First North listing as a means to raise capital and investor awareness”.
Corline Biomedical AB has appointed Sedermera Fondkommission as Certified Adviser.
*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.
About Nasdaq First North
Nasdaq First North is regulated as a multilateral trading facility, operated by the different exchanges within Nasdaq Nordic (Nasdaq First North Denmark is regulated as an alternative marketplace). It does not have the legal status as an EU-regulated market. Companies at Nasdaq First North are subject to the rules of Nasdaq First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market”
Nasdaq (Nasdaq: NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of over $9.5 trillion and more than 10,000 corporate clients. To learn more, visit nasdaq.com/ambition or business.nasdaq.com.
Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq OMX Copenhagen A/S, Nasdaq OMX Helsinki Ltd., Nasdaq OMX Iceland hf., Nasdaq OMX Riga, AS, Nasdaq OMX Stockholm AB, Nasdaq OMX Tallinn AS, AB Nasdaq OMX Vilnius, Nasdaq OMX Clearing AB, Nasdaq OMX Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
|Media Relations Contact:|
|+46 8 405 6639|